Publisher
Springer Nature Singapore
Reference19 articles.
1. A Contemporary History of the Japanese Pharmaceutical Industry (1980–2010) Task Force. (2014). A Contemporary History of the Japanese Pharmaceutical Industry (1980–2010). Jpn J Hist Pharmacy, 49, 18–38.
2. Anegawa, T. (2002). Japanese pharmaceutical industry: Success and failure. J Health Care Med Commun, 12(2), 49–78.
3. Cockburn, I. M., Lanjouw, J. O., & Schankerman, M. (2016). Patents and the global diffusion of new drugs. The American Economic Review, 106, 136–164.
4. Cohen, W. M., Goto, A., Nagata, A., et al. (2002). R&D spillovers, patents and the incentives to innovate in Japan and the United States. Research Policy, 31, 1349–1367.
5. DiMasi, J. A., & Faden, L. B. (2011). Competitiveness in follow-on drug R&D: A race or imitation? Nature Reviews Drug Discovery, 10, 23–27.